Work

Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer

Year: 2020

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2020.05.372

Authors: A. Staley, K. Tucker, Z. Fang, Y. Fan, W. Sun, Y. Yin, Y. Zhang, V.V. Prabhu, J.E. Allen, M. Stogniew, C. Zhou, V.L. Bae-Jump

Institutions: University of North Carolina at Chapel Hill, Oncoceutics (United States), UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer

OpenAlex ID: W4206896208

FWCI: 0.915

Cites: 3

Cited by: 15

Related to: 10